Apollo Medical Holdings, Inc. - AMEH Enterprise Value-to-Revenue Multiple

Public company logo of Apollo Medical Holdings Inc. (AMEH)

Long-term contracts with US physicians have created a robust defensive barrier, triggering a sharp surge in the valuation of Apollo Medical Holdings (AMEH) based on the EV/Sales multiple shown on this GURU.Markets platform chart. Today, 454.14 expresses the current value of this metric. Growth is supported by the expansion of cloud B2B platforms within hospitals and an ESG approach that reduces transport emissions through the digitalization of medicine.

AMEH: Apollo Medical Holdings Inc. EV/Sales Multiple 11/23/2025 - 11/20/2026

Apollo Medical Holdings - analytical breakdowns and key metrics (AMEH)

- market value and analyst target forecast:
- issuer market value details:
Initial company analysis:Apollo Medical Holdings - AMEH
Manufactured product of ApolloMed

This indicator determines the business value inclusive of net debt per unit of revenue, allowing investors to identify asset overvaluation relative to actual operating income. By analyzing the EV/Sales ratio, the market assesses the stability of Apollo Medical Holdings (AMEH), whose defensive business model featuring long-term Medicare contracts minimizes volatility risks regardless of the current economic cycle.

Direct competitors

Enterprise Value-to-Revenue Multiple veeva.com|DOCS (Doximity) - Company Value to Revenue|HQY - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio Waystar Inc.|CRVL: Business Value to Revenue|Enterprise Value-to-Revenue Ratio Privia Health Group (PRVA)|EV/Sales Multiple huronconsultinggroup.com (HURN)|Certara Inc - Company Value to Revenue|OMCL - Company Value to Revenue|GDRX - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio Schrodinger Corp SDGR|PHR: EV/Sales Multiple|OMDA - Total Company Value-to-Revenue Ratio|EVH (Evolent Health Inc) - EV/Sales Multiple|Company Value to Revenue Ratio HSTM (HealthStream)|EV/Sales Multiple DH|CCSI (Consensus Corp) - Business Value to Revenue|agilon health Inc - Company Value to Revenue|absci.com - Enterprise Value-to-Revenue Ratio|SY - Enterprise Value-to-Revenue Ratio|Business Value to Revenue NRC (National Research)|USA Mobility (SPOK) - Enterprise Value-to-Revenue Ratio|OPRX: Enterprise Value-to-Revenue Coefficient|Company Value to Revenue TBRG|simulations-plus.com (SLP) - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio sophiagenetics.com (SOPH)|HCAT (Health Catalyst) - Business Value to Revenue|Enterprise Value-to-Revenue Ratio CareCloud, Inc. CCLD|Total Company Value-to-Revenue Ratio Research Solutions (RSSS)|DLH Corp - EV/Sales Multiple|ONMD (OneMedNet) - Company Value to Revenue Ratio|SCNX: EV/Sales Multiple|HCTI - Total Company Value-to-Revenue Ratio|ISPC (iSpecimen) - EV/Sales Multiple|Bullfrog AI (BFRG) - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio SCWorx Corp (WORX)|msprecovery.com - Company Value to Revenue Ratio|EV/Sales Multiple ICCT (icoreconnect.com)|TRxADE HEALTH (MEDS) - Enterprise Value-to-Revenue Multiple|orgenesis.com - EV/Sales Multiple|R1 RCM, Inc. (RCM) - Company Value to Revenue|SHCR: EV/Sales Multiple|STRM: Enterprise Value-to-Revenue Coefficient|Enterprise Value-to-Revenue Ratio Syra Health|MODN: Business Value to Revenue|Company Value to Revenue NXGN (NextGen Healthcare)